<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="295">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 24, 2013</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01272622</url>
  </required_header>
  <id_info>
    <org_study_id>DKSR 463</org_study_id>
    <nct_id>NCT01272622</nct_id>
  </id_info>
  <brief_title>Prospective Study of Children and Adolescents With Craniopharyngioma</brief_title>
  <official_title>KRANIOPHARYNGEOM 2007 - Multicenter Prospective Study of Children and Adolescents With Craniopharyngioma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum Oldenburg gGmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German society of pediatric oncology and hematology (GPOH)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Association of pediatric endocrinology (APE)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>German Society for Endocrinology (DGE)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Working group pediatric radiation oncology (APRO)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Task force of the German society of radiation oncology (DEGRO)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Deutsche Kinderkrebsstiftung (DKKS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Klinikum Oldenburg gGmbH</source>
  <oversight_info>
    <authority>Germany: Ethical board</authority>
    <authority>Germany: Federal Office for Radiation Protection</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present investigation is a prospective, multicenter study evaluating craniopharyngioma
      patients' prognoses following the various currently-practiced therapeutic strategies.Primary
      goals of the study are to establish quality standards and compare the various therapy
      strategies with respect to their effectiveness and impact on the quality of life of treated
      patients. A stratified randomization of two treatment arms will be conducted with respect to
      timing of postoperative irradiation for the subgroup of patients ≥5 years of age whose
      tumors are incompletely resected. The researchers will investigate whether an immediate,
      postoperative irradiation is superior to progression-contingent irradiation based on
      alterations to quality of life (PEDQOL) from the time randomization is initiated (3rd month
      post op) to 3 years after randomization. Progression-free survival and overall survival will
      be examined as closely-related subgoals.Postoperative data will be evaluated via a
      surveillance study for all complete resection patients as well as for those patients under 5
      years of age regardless of their resection grade.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>3 years after diagnosis</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>•Randomized investigation of children (≥ 5 years of age) and adolescent QoL changes (main goal assessment) following incomplete craniopharyngioma resections at primary diagnosis per QoL endpoint scores (PEDQOL &quot;physical functions&quot; domain) measured from 3rd month after surgery for 3 years after randomization; and the progression-free and total survival rates (subgoal assessments) relative to how these rates relate to postoperative irradiation timing (immediate postsurgery irradiation versus wait-and-see approach + progression-contingent irradiation of residual tumor).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of Progression or relapse</measure>
    <time_frame>3 years after surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>Compilation of applied therapy strategies for craniopharyngiomas in children and adolescents using data capture conforming to SIOP brain tumor groups
Evaluation of patients' remission status following the various therapy strategies/modalities for craniopharyngiomas using data detection consistent with SIOP brain tumor groups
Evaluation of the health status (ophthalmologic, neuropsychologic and endocrine conditions) and health-related QoL of children and adolescents following treatment of craniopharyngiomas using data capture conforming to SIOP brain tumor groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Craniopharyngioma</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Arm I</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Children and adolescents &gt;= 18 years of age new diagnosed with craniopharyngioma
&gt;= 5 years of age and with incomplete resected tumor =&gt; randomized in two arms: immediate irradiation after surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>incomplete resection and irradiation at the time of progression of residual tumor</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiation</intervention_name>
    <description>Immediate irradiation after incomplete resection (fractionated, percutaneous irradiation, 54 gy)</description>
    <arm_group_label>Arm I</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>wait and watch</intervention_name>
    <description>wait ans watch, MRI controls, irradiation at the time of progression of residual tumor</description>
    <arm_group_label>Arm II</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diagnosed with craniopharyngioma for the first time

          2. Age at diagnosis 18 years or less of age

          3. Agreement from patient's parents or legal guardian as well as the patient

        Criteria for inclusion in randomization study

          1. Histological diagnosis of craniopharyngioma

          2. Age at diagnosis 18 years or less of age

          3. Age at primary surgery over 5 years of age

          4. Incomplete primary resection

          5. Reference radiological confirmation of an incomplete resection

          6. Agreement from patient's parents or legal guardian as well as the patient

        Exclusion Criteria:

        Age at diagnosis over 18 years of age No QoL measurement for randomization (3 months after
        surgery).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hermann L Mueller, MD</last_name>
    <phone>+49 441 403</phone>
    <phone_ext>2013</phone_ext>
    <email>mueller.hermann@klinikum-oldenburg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ursel Gebhardt, phD</last_name>
    <phone>+49 403 441</phone>
    <phone_ext>2072</phone_ext>
    <email>kikra.doku@klinikum-oldenburg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinikum Oldenburg</name>
      <address>
        <city>Oldenburg</city>
        <state>Niedersachsen</state>
        <zip>26133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hermann L Mueller, MD</last_name>
      <phone>+49 441 403</phone>
      <phone_ext>2013</phone_ext>
      <email>mueller.hermann@klinikum-oldenburg.de</email>
    </contact>
    <contact_backup>
      <last_name>Ursel Gebhardt, phD</last_name>
      <phone>+49 441 403</phone>
      <phone_ext>2072</phone_ext>
      <email>kikra.doku@klinikum-oldenburg.de</email>
    </contact_backup>
    <investigator>
      <last_name>Hermann L Mueller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://kraniopharyngeom.net</url>
    <description>Study Protocol and information about the ongoing trial</description>
  </link>
  <verification_date>July 2011</verification_date>
  <lastchanged_date>August 8, 2011</lastchanged_date>
  <firstreceived_date>January 7, 2011</firstreceived_date>
  <responsible_party>
    <name_title>Prof. Dr. Hermann Mueller</name_title>
    <organization>Klinikum Oldenburg gGmbH</organization>
  </responsible_party>
  <keyword>Quality of life</keyword>
  <keyword>Endocrinology</keyword>
  <keyword>Oncology</keyword>
  <keyword>Hypothalamus</keyword>
  <keyword>Irradiation</keyword>
  <keyword>Neurosurgery</keyword>
  <keyword>Pediatric Brain tumors</keyword>
  <keyword>Randomized trial</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Craniopharyngioma</mesh_term>
    <mesh_term>Adamantinoma</mesh_term>
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
